Zoetis Inc.
▲ 1 upgrades / ▼ 1 downgrades / 0 reiterations from 2 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Oct 16, 2026 | Goldman Sachs | initiate | — → Neutral | — | 54% |
| Aug 25, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 20, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| Aug 11, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 11, 2026 | BNP Paribas | maintain | Outperform → Outperform | — | 52% |
| Aug 10, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 6, 2026 | William Blair | downgrade | Outperform → Market Perform | — | 48% |
| Jul 27, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 22, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jul 6, 2026 | HSBC | maintain | Buy → Buy | — | 53% |
| Jul 1, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jun 30, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jun 26, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| May 27, 2026 | Argus Research | downgrade | Buy → Hold | — | 54% |
| May 22, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| May 18, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 8, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| May 8, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Apr 28, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 15, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Feb 13, 2026 | B of A Securities | maintain | Neutral → Neutral | $140 | 53% |
| Jan 22, 2026 | Piper Sandler | downgrade | Overweight → Neutral | $135 | 54% |
| Dec 9, 2025 | Barclays | initiate | — → Equal-Weight | $136 | 53% |
| Dec 3, 2025 | BTIG | reiterate | Buy → Buy | $160 | 52% |
| Nov 21, 2025 | Keybanc | initiate | — → Sector Weight | $0 | 53% |
| Nov 18, 2025 | Stifel | maintain | Hold → Hold | $130 | 53% |
| Nov 12, 2025 | BTIG | maintain | Buy → Buy | $160 | 52% |
| Nov 10, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $175 | 54% |
| Nov 5, 2025 | UBS | maintain | Neutral → Neutral | $141 | 54% |
| Nov 5, 2025 | JP Morgan | maintain | Overweight → Overweight | $200 | 54% |
| Oct 20, 2025 | UBS | maintain | Neutral → Neutral | $158 | 54% |
| Sep 9, 2025 | Argus Research | reiterate | Buy → Buy | $190 | 54% |
| Aug 11, 2025 | Piper Sandler | maintain | Overweight → Overweight | $215 | 54% |
| Jul 17, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $155 | 50% |
| Jun 18, 2025 | Stifel | downgrade | Buy → Hold | $160 | 53% |
| May 12, 2025 | Piper Sandler | maintain | Overweight → Overweight | $210 | 54% |
| May 7, 2025 | UBS | maintain | Neutral → Neutral | $170 | 54% |
| Apr 14, 2025 | Stifel | maintain | Buy → Buy | $165 | 53% |
| Feb 27, 2025 | Piper Sandler | maintain | Overweight → Overweight | $205 | 54% |
| Feb 14, 2025 | Barclays | maintain | Overweight → Overweight | $244 | 53% |
| Feb 14, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $238 | 54% |
| Feb 10, 2025 | Piper Sandler | maintain | Overweight → Overweight | $200 | 54% |
| Jan 29, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $243 | 54% |
| Jan 7, 2025 | Stifel | maintain | Buy → Buy | $180 | 53% |
| Dec 9, 2024 | UBS | initiate | — → Neutral | $196 | 54% |
| Dec 2, 2024 | Leerink Partners | initiate | — → Outperform | $215 | 50% |
| Oct 11, 2024 | JP Morgan | maintain | Overweight → Overweight | $230 | 54% |
No cross-platform signals in the last 90 days